During the past five years, more than five million women in Southwest China's Guizhou Province have received free breast- and/or cervical-cancer screenings.
A health-service network, which integrates cancer screening, treatments, follow-up visits, assistance and prevention, has been established in Guizhou.
To provide screening services to women living in remote areas, medical workers have traveled, via medical vehicles, to women's homes.
In 2024, Lu Honglin, project manager with the maternal- and infant-care hospital in Anshun, a city in Guizhou, led her team in conducting the cervical-cancer screenings of more than 58,000 women, and the breast-cancer screenings of more than 59,000 women.
Since 2023, the human papillomavirus (HPV) gene test technology has been used as the top option for cervical-cancer screening in all regions of Guizhou. The technology can accurately discover the risk of cervical cancer at an early stage. A tier-based diagnosis and treatment system has also ensured patients receive highly efficient, whole-process services.
To promote early screenings, early diagnoses and early treatments, governments, at all levels in Guizhou, have conducted both online and offline publicity activities.
(Women of China English Monthly March 2026)
Editor: Wang Shasha
